We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
+25.23%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$133M
AUM Growth
-$56M
Cap. Flow
-$72M
Cap. Flow %
-54.02%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
RSLS
ReShape Lifesciences Inc. Common Stock
RSLS
+$3.41M

Top Sells

Rank Stock Value
1
ENTL
Entellus Medical, Inc. Common Stock
ENTL
+$72.1M
2
ETRM
EnteroMedics Inc.
ETRM
+$3.33M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XFOR icon
1
X4 Pharmaceuticals
XFOR
$419M
$42.8M 32.08%
10,383
– –
DCPH
2
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$34.4M 25.79%
1,716,303
– –
KALV
3
DELISTED
KalVista Pharmaceuticals
KALV
$24.5M 18.34%
2,579,490
– –
ASXC
4
DELISTED
Asensus Surgical, Inc.
ASXC
$12.8M 9.62%
580,515
– –
OCUL icon
5
Ocular Therapeutix
OCUL
$2.38B
$10.4M 7.84%
1,605,207
– –
ATXS
6
DELISTED
Astria Therapeutics
ATXS
$5.17M 3.88%
47,628
– –
RSLS
7
DELISTED
ReShape Lifesciences Inc. Common Stock
RSLS
$3.26M 2.45%
+1,072
New +$3.41M
ENTL
8
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
– –
-2,956,456
Closed -$72.1M
ETRM
9
DELISTED
EnteroMedics Inc.
ETRM
– –
-2,250,958
Closed -$3.33M

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q1 2018 Portfolio in Review

As of Q1 2018, SV Health Investors held 9 positions worth $133M, down 30% from $189M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors withdrew a net $72M in Q1 2018, closing 2 positions. Its most notable exit was Entellus Medical, Inc. Common Stock, an estimated $72.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, SV Health Investors opened a new position in ReShape Lifesciences Inc. Common Stock worth $3.26M.

  • SV Health Investors's largest Q1 2018 buy was ReShape Lifesciences Inc. Common Stock: 1,072 shares worth $3.26M.
  • SV Health Investors fully exited Entellus Medical, Inc. Common Stock in Q1 2018, selling an estimated $72.1M.
  • SV Health Investors's ten largest holdings make up 100% of its $133M portfolio in Q1 2018.
  • SV Health Investors opened 1 new position and closed 2 in Q1 2018.
  • SV Health Investors's portfolio value fell 30% quarter-over-quarter to $133M.

Based on SV Health Investors's 13F filing for Q1 2018, filed 15 May 2018.